Life Sciences Academy | New Trump Administration and Impact on the Life Science Industry

With multiple biotech and pharma hubs and world class research institutions, the United States is by some distance the world leader in life sciences R&D. For a large number of our clients, the US is also a core market for their products. Keeping abreast of regulatory and practical developments around doing business in the US is essential to maintaining commercial success.

Join us for an insightful webinar where our experts will interview Michael P. Strazella, Senior Principal, Co-Head of Government Relations and Health Industry at Buchanan. Michael will share his expertise on the latest policy developments under the new Trump Administration and their implications for the life sciences and healthcare sectors.